SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-284633
Filing Date
2022-11-14
Accepted
2022-11-14 16:21:45
Documents
2
Group Members
ALAN FRAZIERALBERT CHABRIAN MORFITTDANIEL ESTESFHM VII, L.L.C.FHM VII, L.P.FHMLS XI, L.L.C.FHMLS XI, L.P.FHMLSP OVERAGE, L.L.C.FHMLSP OVERAGE, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER HEALTHCARE VII-A, L.P.FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.FRAZIER LIFE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d403821dsc13da.htm SC 13D/A 506030
2 EX-A d403821dex99a.htm EX-99.A 35592
  Complete submission text file 0001193125-22-284633.txt   543897
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Healthcare VII, L.P. (Filed by) CIK: 0001553071 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065
Business Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065 (415) 529-5055
Imago BioSciences, Inc. (Subject) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92697 | Film No.: 221385895
SIC: 2834 Pharmaceutical Preparations